Elicia Penuel Selected Research

Elicia Penuel Research Topics

Disease

15	Neoplasms (Cancer) 01/2019 - 08/2002
7	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2024 - 01/2019
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2023 - 05/2019
4	Breast Neoplasms (Breast Cancer) 03/2011 - 03/2009
3	Disease Progression 12/2023 - 06/2015
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 02/2018
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2015 - 06/2013
2	Melanoma (Melanoma, Malignant) 11/2018 - 07/2012
2	Squamous Cell Carcinoma of Head and Neck 12/2016 - 01/2016
1	Hematologic Diseases (Blood Diseases) 10/2023
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2020
1	Neoplasm Metastasis (Metastasis) 01/2019
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2018
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 12/2016
1	Infections 01/2016
1	Chills 06/2015
1	Headache (Headaches) 06/2015
1	Fever (Fevers) 06/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2015
1	Colorectal Neoplasms (Colorectal Cancer) 06/2015
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2014
1	Glioma (Gliomas) 01/2011

Drug/Important Bio-Agent (IBA)

6	LigandsIBA 12/2016 - 01/2011
5	Biomarkers (Surrogate Marker)IBA 11/2018 - 06/2013
5	Proteins (Proteins, Gene)FDA Link 12/2014 - 08/2002
4	Formaldehyde (Formol)FDA Link 01/2019 - 03/2009
4	ParaffinIBA 01/2019 - 03/2009
3	Monoclonal AntibodiesIBA 01/2022 - 08/2010
3	polatuzumab vedotinIBA 10/2020 - 01/2019
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 11/2018 - 07/2012
3	MEHD7945AIBA 12/2016 - 06/2015
3	Trastuzumab (Herceptin)FDA Link 03/2011 - 08/2010
2	Bispecific AntibodiesIBA 01/2024 - 12/2023
2	atezolizumabIBA 01/2022 - 01/2022
2	obinutuzumabIBA 01/2022 - 01/2019
2	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 01/2019
2	Rituximab (Mabthera)FDA Link 05/2019 - 01/2019
2	VemurafenibIBA 11/2018 - 07/2012
2	ErbB Receptors (EGF Receptor)IBA 12/2016 - 03/2010
2	Neuregulin-1 (Neuregulin 1)IBA 01/2016 - 06/2015
2	Messenger RNA (mRNA)IBA 12/2014 - 09/2014
2	onartuzumabIBA 09/2014 - 06/2013
2	Phosphotransferases (Kinase)IBA 07/2012 - 08/2010
1	Chimeric Antigen ReceptorsIBA 04/2024
1	AntigensIBA 12/2023
1	AnthracyclinesIBA 12/2023
1	Alkylating AgentsIBA 01/2022
1	tazemetostatIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	pinatuzumab vedotinIBA 05/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019
1	Prednisone (Sone)FDA LinkGeneric 01/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019
1	Dacarbazine (DIC)FDA LinkGeneric 11/2018
1	Circulating Tumor DNAIBA 11/2018
1	fenebrutinibIBA 02/2018
1	Cisplatin (Platino)FDA LinkGeneric 12/2016
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2016
1	Carboplatin (JM8)FDA LinkGeneric 12/2016
1	Fluorouracil (Carac)FDA LinkGeneric 12/2016
1	Agammaglobulinaemia Tyrosine KinaseIBA 10/2016
1	ibrutinibIBA 10/2016
1	Cetuximab (Erbitux)FDA Link 01/2016
1	Small Interfering RNA (siRNA)IBA 12/2014
1	Matrix Metalloproteinases (MMPs)IBA 12/2014
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2014
1	AmphiregulinIBA 09/2014
1	EpiregulinIBA 09/2014
1	tyrosine receptor (receptor, tyrosine)IBA 07/2012
1	Mitogen-Activated Protein KinasesIBA 07/2012
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 07/2012
1	Indicators and Reagents (Reagents)IBA 01/2011
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2011
1	Tyrosine (L-Tyrosine)FDA Link 01/2011
1	Estrogen ReceptorsIBA 08/2010

Therapy/Procedure

8	Therapeutics 01/2024 - 03/2010
3	Drug Therapy (Chemotherapy) 12/2016 - 07/2012
1	Immunotherapy 01/2024
1	Transplantation 10/2020
1	Premedication 06/2015